470 results on '"Lega, Jean‐Christophe"'
Search Results
52. La maladie associée aux immunoglobulines G4
53. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
54. Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in France
55. Patients’ perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy
56. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies
57. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus
58. Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
59. The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome
60. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis
61. Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: A retrospective multicenter study
62. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study
63. Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry
64. Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry
65. Population designations in biomedical research: Limitations and perspectives
66. Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides
67. Thromboprophylaxie en médecine : quelles modifications avec les nouveaux anticoagulants oraux ?
68. Nouveaux anticoagulants oraux dans la fibrillation atriale non valvulaire
69. Nouveaux anticoagulants oraux dans le traitement curatif de la maladie thromboembolique veineuse
70. Causes and consequences of variation in offspring body mass: meta‐analyses in birds and mammals
71. Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies
72. Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
73. Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of Vaccination
74. Nécessité d’améliorer nos connaissances sur les pneumopathies interstitielles diffuses associées aux connectivites
75. The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)
76. Cryoglobulinemia in Systemic Lupus Erythematosus: A Retrospective Study of 213 Patients
77. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome
78. A call for evidence in connective tissue diseases-associated interstitial lung disease
79. Inflammation of Unknown Origin: Evaluation and Prognosis of 57 Cases
80. Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients
81. Risk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies
82. Therapeutic options in VEXAS syndrome: insights from a retrospective series
83. Editor’s Note on “Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: An estimate” [Biomedicine & Pharmacotherapy, 171 (2024) 116055]
84. Population designations in biomedical research: Limitations and perspectives.
85. Prognostic value of troponins in sepsis: a meta-analysis
86. Abstract 10351: Validity and Relevance of Clinical Worsening as a Composite Endpoint in Pulmonary Arterial Hypertension Trials
87. Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment
88. Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment
89. VEXAS syndrome-related AA amyloidosis: a case report
90. Comparaison de la gravité des intoxications à la chloroquine et de l’hydroxychloroquine. Une étude rétrospective
91. Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response
92. Assessing the management of major bleeding events in patients treated by direct oral anticoagulant in an emergency department
93. Screening for hypertension-mediated organ damage and aetiology: still of value after 65 years of age?
94. Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients.
95. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial
96. French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
97. Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis
98. Pathway of Suspected-COVID-19 Patients From French Emergency Departments During The First Outbreak: A Prospective Controlled Cohort Study
99. Paraneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma
100. Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.